000873615 001__ 873615
000873615 005__ 20210130004458.0
000873615 0247_ $$2doi$$a10.1038/s41531-019-0107-3
000873615 0247_ $$2Handle$$a2128/24211
000873615 0247_ $$2altmetric$$aaltmetric:74140708
000873615 0247_ $$2pmid$$apmid:31970287
000873615 0247_ $$2WOS$$aWOS:000510945800001
000873615 037__ $$aFZJ-2020-00858
000873615 082__ $$a610
000873615 1001_ $$00000-0001-9227-5973$$aPelzer, Esther A.$$b0$$eCorresponding author
000873615 245__ $$aHypomania and saccadic changes in Parkinson’s disease: influence of D2 and D3 dopaminergic signalling
000873615 260__ $$aLondon [u.a.]$$bNature Publ. Group$$c2020
000873615 3367_ $$2DRIVER$$aarticle
000873615 3367_ $$2DataCite$$aOutput Types/Journal article
000873615 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1580826700_4614
000873615 3367_ $$2BibTeX$$aARTICLE
000873615 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000873615 3367_ $$00$$2EndNote$$aJournal Article
000873615 520__ $$aIn order to understand the influence of two dopaminergic signalling pathways, TaqIA rs1800497 (influencing striatal D2 receptor density) and Ser9Gly rs6280 (influencing the striatal D3 dopamine-binding affinity), on saccade generation and psychiatric comorbidities in Parkinson’s disease, this study aimed to investigate the association of saccadic performance in hypomanic or impulsive behaviour in parkinsonian patients; besides we questioned whether variants of D2 (A1+/A1−) and D3 (B1+/B1−) receptor polymorphism influence saccadic parameters differently, and if clinical parameters or brain connectivity changes modulate this association in the nigro-caudatal and nigro-collicular tract. Initially, patients and controls were compared regarding saccadic performance and differed in the parameter duration in memory-guided saccades (MGS) and visually guided saccades (VGS) trials (p < 0.0001) and in the MGS trial (p < 0.03). We were able to find associations between hypomanic behaviour (HPS) and saccade parameters (duration, latency, gain and amplitude) for both conditions [MGS (p = 0.036); VGS (p = 0.033)], but not for impulsive behaviour. For the A1 variant duration was significantly associated with HPS [VGS (p = 0.024); MGS (p = 0.033)]. In patients with the B1 variant, HPS scores were more consistently associated with duration [VGS (p = 0.005); MGS (p = 0.015), latency [VGS (p = 0.022)]] and amplitude [MGS (p = 0.006); VGS (p = 0.005)]. The mediation analysis only revealed a significant indirect effect for amplitude in the MGS modality for the variable UPDRS-ON (p < 0.05). All other clinical scales and brain connectivity parameters were not associated with behavioural traits. Collectively, our findings stress the role of striatal D2 and D3 signalling mechanisms in saccade generation and suggest that saccadic performance is associated with the clinical psychiatric state in Parkinson’s disease.
000873615 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000873615 588__ $$aDataset connected to CrossRef
000873615 7001_ $$00000-0001-8239-1110$$aDillenburger, Barbara$$b1
000873615 7001_ $$0P:(DE-HGF)0$$aGrundmann, Sophie$$b2
000873615 7001_ $$0P:(DE-HGF)0$$aIliaev, Vladimir$$b3
000873615 7001_ $$0P:(DE-HGF)0$$aAschenberg, Sophie$$b4
000873615 7001_ $$0P:(DE-HGF)0$$aMelzer, Corina$$b5
000873615 7001_ $$0P:(DE-HGF)0$$aHess, Martin$$b6
000873615 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b7$$ufzj
000873615 7001_ $$0P:(DE-HGF)0$$aEggers, Carsten$$b8
000873615 7001_ $$0P:(DE-HGF)0$$aTittgemeyer, Marc$$b9
000873615 7001_ $$0P:(DE-HGF)0$$aTimmermann, Lars$$b10
000873615 773__ $$0PERI:(DE-600)2819218-7$$a10.1038/s41531-019-0107-3$$gVol. 6, no. 1, p. 5$$n1$$p5$$tnpj Parkinson's Disease$$v6$$x2373-8057$$y2020
000873615 8564_ $$uhttps://juser.fz-juelich.de/record/873615/files/Pelzer_NPJ%20Parkinsons%20Dis_2020_Hypomania%20and%20saccadic%20changes%20in%20Parkinson%27s%20disease.pdf$$yOpenAccess
000873615 8564_ $$uhttps://juser.fz-juelich.de/record/873615/files/Pelzer_NPJ%20Parkinsons%20Dis_2020_Hypomania%20and%20saccadic%20changes%20in%20Parkinson%27s%20disease.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000873615 909CO $$ooai:juser.fz-juelich.de:873615$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000873615 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b7$$kFZJ
000873615 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000873615 9141_ $$y2020
000873615 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000873615 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000873615 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index
000873615 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000873615 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000873615 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000873615 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000873615 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000873615 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000873615 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000873615 920__ $$lyes
000873615 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000873615 980__ $$ajournal
000873615 980__ $$aVDB
000873615 980__ $$aUNRESTRICTED
000873615 980__ $$aI:(DE-Juel1)INM-3-20090406
000873615 9801_ $$aFullTexts